How do you pay?

How to pay the least

From

$13.25 for 30 tablets delivered ($8 plus $5.25 shipping)

Generic olanzapine from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic olanzapine. It comes by mail.

Need it today? From $16.55 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

A regular generic has the same active ingredient as ZYPREXA Zydis, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameZYPREXA Zydis
Authorized genericolanzapine
Regular genericolanzapine
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
From$13.25for 30 tablets at Cost Plus Drugs, with shipping
Same as ZYPREXA Zydis?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameNo maker’s card

We didn’t find a savings card or cash price from ZYPREXA Zydis’s maker. Ask the pharmacy for ZYPREXA Zydis’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is ZYPREXA Zydis itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic olanzapine, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

7 companies sell a generic of ZYPREXA Zydis that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • ApotexAll 4 strengths
    Packages and NDCs

    5 mg

    PackageNDC
    Bottle of 3060505-3275-3
    Carton of 10060505-3275-0
    Bottle of 100060505-3275-8

    10 mg

    PackageNDC
    Bottle of 3060505-3276-3
    Carton of 10060505-3276-0
    Bottle of 100060505-3276-8

    15 mg

    PackageNDC
    Bottle of 3060505-3277-3
    Carton of 10060505-3277-0
    Bottle of 100060505-3277-8

    20 mg

    PackageNDC
    Bottle of 3060505-3278-3
    Carton of 10060505-3278-0
    Bottle of 100060505-3278-8
  • Dr. Reddy’s LaboratoriesAll 4 strengths
    How it looks, what’s in it, NDCs

    5 mg Yellow, capsule, 7 mm, marked “R262”

    PackageNDC
    Blister pack of 1055111-262-79
    Carton of 3055111-262-81

    10 mg Yellow, capsule, 7 mm, marked “R263”

    PackageNDC
    Blister pack of 1055111-263-79
    Carton of 3055111-263-81

    15 mg Yellow, capsule, 8 mm, marked “R264”

    PackageNDC
    Blister pack of 1055111-264-79
    Carton of 3055111-264-81

    20 mg Yellow, capsule, 9 mm, marked “R265”

    PackageNDC
    Blister pack of 1055111-265-79
    Carton of 3055111-265-81

    Inactive ingredients: crospovidone, aspartame, silicon dioxide, mannitol, cellulose, microcrystalline, starch, corn, sodium lauryl sulfate, magnesium stearate

    FDA label

  • HEC PharmAll 4 strengths
    How it looks, what’s in it, NDCs

    5 mg Yellow or almost-yellow, round, 6 mm, marked “L32”

    PackageNDC
    Bottle of 3072303-0841-1

    10 mg Yellow or almost-yellow, round, 8 mm, marked “L33”

    PackageNDC
    Bottle of 3072303-0842-1

    15 mg Yellow or almost-yellow, round, 9 mm, marked “L35”

    PackageNDC
    Bottle of 3072303-0843-1

    20 mg Yellow or almost-yellow, round, 10 mm, marked “L37”

    PackageNDC
    Bottle of 3072303-0844-1

    Inactive ingredients: aspartame, crospovidone, magnesium stearate, mannitol, cellulose, microcrystalline, sodium stearyl fumarate

    FDA label

  • Macleods PharmaceuticalsAll 4 strengths
    How it looks, what’s in it, NDCs

    5 mg Yellow, round, 5 mm, marked “ML35”

    PackageNDC
    Container of 3033342-083-07
    Container of 10033342-083-11
    Carton of 10033342-083-12
    Container of 100033342-083-44

    10 mg Yellow, round, 7 mm, marked “ML36”

    PackageNDC
    Container of 3033342-084-07
    Container of 10033342-084-11
    Carton of 10033342-084-12
    Container of 100033342-084-44

    15 mg Yellow, round, 8 mm, marked “ML37”

    PackageNDC
    Container of 3033342-085-07
    Container of 10033342-085-11
    Carton of 10033342-085-12
    Container of 50033342-085-15

    20 mg Yellow, round, 9 mm, marked “CL1”

    PackageNDC
    Container of 3033342-086-07
    Container of 10033342-086-11
    Carton of 10033342-086-12
    Container of 50033342-086-15

    Inactive ingredients: aspartame, cellulose, microcrystalline, hydroxypropyl cellulose, crospovidone, magnesium stearate

    FDA label

  • Strides Pharma ScienceAll 4 strengths
    How it looks, what’s in it, NDCs

    5 mg Yellow, round, 6 mm, marked “P / 320”

    PackageNDC
    Carton of 3064380-172-02

    10 mg Yellow, round, 8 mm, marked “P / 321”

    PackageNDC
    Carton of 3064380-173-02

    15 mg Yellow, round, 10 mm, marked “P / 322”

    PackageNDC
    Carton of 3064380-174-02

    20 mg Yellow, round, 12 mm, marked “P / 323”

    PackageNDC
    Carton of 3064380-175-02

    Inactive ingredients: aspartame, mannitol, silicon dioxide, sorbitol, talc, magnesium sulfate, crospovidone

    FDA label

  • Teva PharmaceuticalsAll 4 strengths

    Made by Barr

    How it looks, what’s in it, NDCs

    5 mg Yellow, round, 7 mm, marked “TV / U1 / 5”

    PackageNDC
    Carton of 300093-5245-65

    10 mg Yellow, round, 9 mm, marked “TV / U2 / 10”

    PackageNDC
    Carton of 300093-5246-65

    15 mg Yellow, round, 10 mm, marked “TV / U7 / 15”

    PackageNDC
    Carton of 300093-5247-65

    20 mg Yellow, round, 12 mm, marked “TV / U4 / 20”

    PackageNDC
    Carton of 300093-5248-65

    Inactive ingredients: aspartame, cellulose, microcrystalline, crospovidone (15 mpa.s at 5%), magnesium stearate, mannitol, silicon dioxide, sodium stearyl fumarate, strawberry, xylitol

    FDA label

  • Torrent PharmaceuticalsAll 4 strengths
    How it looks, what’s in it, NDCs

    5 mg Yellow, round, 6 mm, marked “86 / 5”

    PackageNDC
    Bottle of 3013668-086-30
    Bottle of 9013668-086-90
    Bottle of 50013668-086-05

    10 mg Yellow, round, 8 mm, marked “88 / 10”

    PackageNDC
    Bottle of 3013668-088-30
    Bottle of 9013668-088-90
    Bottle of 50013668-088-05

    15 mg Yellow, round, 10 mm, marked “89 / 15”

    PackageNDC
    Bottle of 3013668-089-30
    Bottle of 9013668-089-90
    Bottle of 50013668-089-05

    20 mg Yellow, round, 11 mm, marked “90 / 20”

    PackageNDC
    Bottle of 3013668-090-30
    Bottle of 9013668-090-90
    Bottle of 50013668-090-05

    Inactive ingredients: aspartame, cellulose, microcrystalline, crospovidone, magnesium stearate, mannitol

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill my ZYPREXA Zydis, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

ZYPREXA® (olanzapine) is an atypical antipsychotic indicated:

As oral formulation for the:

  • Treatment of schizophrenia.
    • Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial.
    • Adolescents (ages 13-17): Efficacy was established in one 6-week trial in patients with schizophrenia. The increased potential (in adolescents compared with adults) for weight gain and dyslipidemia may lead clinicians to consider prescribing other drugs first in adolescents.
  • Acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder.
    • Adults: Efficacy was established in three clinical trials in patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one maintenance trial.
    • Adolescents (ages 13-17): Efficacy was established in one 3-week trial in patients with manic or mixed episodes associated with bipolar I disorder. The increased potential (in adolescents compared with adults) for weight gain and dyslipidemia may lead clinicians to consider prescribing other drugs first in adolescents.
  • Medication therapy for pediatric patients with schizophrenia or bipolar I disorder should be undertaken only after a thorough diagnostic evaluation and with careful consideration of the potential risks.
  • Adjunct to valproate or lithium in the treatment of manic or mixed episodes associated with bipolar I disorder.
    • Efficacy was established in two 6-week clinical trials in adults. Maintenance efficacy has not been systematically evaluated.

As ZYPREXA IntraMuscular for the:

  • Treatment of acute agitation associated with schizophrenia and bipolar I mania.
    • Efficacy was established in three 1-day trials in adults.

As ZYPREXA and Fluoxetine in Combination for the:

  • Treatment of depressive episodes associated with bipolar I disorder.
    • Efficacy was established with Symbyax (olanzapine and fluoxetine in combination); refer to the product label for Symbyax.
  • Treatment of treatment resistant depression.
    • Efficacy was established with Symbyax (olanzapine and fluoxetine in combination) in adults; refer to the product label for Symbyax.

Source: the FDA label for ZYPREXA Zydis (H2-Pharma LLC), October 6, 2026. Full label on DailyMed 

Good to know